Once cancer cells are disseminated in the bone, interactions between tumour cells and the bone metastatic niche (osteoblasts, haematopoietic stem cells and blood vessels) lead to increased secretion of IL1β in the local environment. This evidence concerns the gene IL1B and neoplasm.